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In this mini-review, we briefly introduce our comprehensive transcriptome analysis through the FANTOM consortium, and then explain our approach for direct cell reprogramming based on our knowledge of transcriptional regulatory networks.
Transcriptional regulation analysis in FANTOM
The FANTOM (Functional ANnoTation Of Mammalian genome) is an international scientific consortium that focuses on mammalian transcriptome analysis. The goal of the FANTOM consortium has been shifting from element analysis to system analysis; mouse full-length cDNAs were sequenced and annotated in the early FANTOMs 1 to 3 resulting in the discovery of a large number of long noncoding RNAs 5-7) , while transcriptional regulatory networks and transcriptional regulatory elements were analyzed to understand gene expression regulation in the recent FANTOMs 4 and 5 8, 9) . In the transcriptome analysis in FANTOMs 4 and 5, we have used our unique technology CAGE (Capped Analysis of Gene Expression) 10, 11) . CAGE is a method to capture capped transcripts followed by the 5'-end sequencing as CAGE tags, providing us with the exact, genome-wide locations of the transcription start sites that are tightly linked with the proximal promoters of the transcripts. In addition, CAGE analysis produces promoterbased expression profiles (promoter activity profiles) since the frequency of a given CAGE tag corresponds to the expression level of the transcript (and the promoter activity)
at the identified transcription start site.
In FANTOM4, we developed a systematic pipeline to produce the promoter-based dynamic transcriptional regulatory network during cell differentiation 8) , in which the CAGE technology was combined with next generation sequencers (deepCAGE). We found that cellular status and functional changes are strictly regulated by concerted actions of transcription factors, with the transcriptional regulatory network being restructured following cell differentiation. In the latest FANTOM5 project, we comprehensively analyzed human and mouse transcripts and their promoters and enhancers 9) , utilizing the further improved non-amplified deepCAGE technology, which removes any bias from sequencing sample construction 10) .
These large-scale data provide us with deep biological insights of many different cell types, including enriched and active key transcription factors.
Concept of transcriptional regulatory network reconstitution
For a given cell, its cellular status, type and function are determined by its overall gene expression levels, which are regulated by the concerted actions of transcription factors forming a robust transcriptional regulatory network. Various transcriptional regulatory networks would contain the shared "common sub-network", responsible for controlling the expression levels of genes involved in common cellular features such as maintenance of structures, small organs, metabolic pathways, transcription and translation systems and repair system etc. For functions specific to each cell type, "cell type specific sub-networks" are involved.
Therefore, direct cell reprograming is considered as the reconstitution of target cell-specific sub-networks into the original cell (Fig.1) ; it is expected that transduction of selected key transcription factors into target cell would induce target cell-specific sub-networks in the original cell while the original cell type-specific sub-networks decline, resulting in the cell reprogrammed with target cell-specific functions and without original cell-specific functions. 
Development of the systematic target cell-specific sub-network reconstitution method
The basic concept of target cell-specific sub-network reconstitution is intuitive. Generation of iPS cells using the Next, in order to evaluate the generality of our method, we used in-house gene expression data with our method to select the important transcription factors for reprogramming of fibroblasts into hepatocytes (Table 1) . Several groups have reported direct reprogramming into mouse and human hepatocytes/hepatoblasts, although distinct sets of transcription factors are used for the reprogramming [13] [14] [15] [16] [17] .
Our method successfully selects the most commonly used transcription factor, FOXA3, and other transcription factors Finally, we compared our method with other well-used methods for direct reprogramming. Both methods consist of three steps, "selection", "screen" and "evaluation", the most distinct step being the "screen" step. Our screen method is based on the construction of transcriptional regulatory networks, whereas other methods depend on phenotype and/or bio-marker expression assays. Furthermore, our method does not rely on any particular prior knowledge in the "selection" step because key transcription factor candidates are automatically calculated using gene expression and literature information. However, this may indicate a limitation of our method when applied to target cell types without much annotation.
Knockdown-mediated direct reprogramming
While the reconstitution of monocyte-specific sub-networks Because the original cell-specific sub-networks may act as barriers to direct cell reprograming, we hypothesized that we may be able to achieve direct cell reprograming if we weaken the robustness of original cell-specific subnetworks by knocking down the key transcription factors.
We , to neural stem cells by overexpression of Oct4 and use of certain drugs 22) and to iPS cells by overexpression of ES-specific miRNAs 
Epigenome as another barrier for direct reprogramming
Epigenomic modification such as histone modification and DNA methylation is strictly controlled in a spatio-temporal manner to regulate gene expression. DNA methylation of cytosine in CpG di-nucleotides at gene promoter regions is considered to be one of the most robust epigenetic marks for gene silencing in terminally differentiated cells 24) . [26] [27] [28] [29] , although the detailed mechanism is still not well understood.
Future perspective
In this mini-review, we described the concept of direct cell reprogramming based on transcriptional regulatory network and our systematic direct reprograming method that should be applicable for any pairs of cell types in any organisms. Although our approach is still not perfect, we hope that further developments will eventually allow us to achieve complete direct cell reprogramming at will. Through the direct cell reprogramming study, we have obtained many biological insights on how genes are positively and negatively regulated by transcriptional regulatory networks and epigenomes. We also found that there are robust mechanisms in terminally differentiated cells that make them not easily reprogrammable by extra stimuli. We believe that the full understanding of these mechanisms will contribute not only to reprogramming, but also to better definition of cell types. Insights into loci-specific DNA methylation modification will also prove to be valuable for medical research, since aberrant DNA methylation of certain genes is one of the major triggers of cancer 30) .
Regenerative medicine using iPS-derived retinal pigment epithelium cells has entered in the clinical study phase, which is the first such case 31) . In the near future, we expect the application of iPS-derived cells for regenerative medicine and drug screens will become more prevalent.
Nonetheless, there are still enough niches for direct cell reprogramming research. For instance, many types of cells have not been able to be differentiated efficiently from iPS/
ES cells yet, and for these cases, direct reprogramming may provide a novel, efficient differentiation method. In order to obtain the reprogrammed cells with high quality in future, it is essential that we continue to improve the direct cell reprograming technologies.
